Trexquant Investment LP decreased its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 84.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 40,368 shares of the company's stock after selling 222,046 shares during the quarter. Trexquant Investment LP's holdings in Cardinal Health were worth $4,774,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Cyrus J. Lawrence LLC acquired a new stake in shares of Cardinal Health in the fourth quarter worth $26,000. Promus Capital LLC bought a new position in shares of Cardinal Health during the fourth quarter valued at $30,000. Lee Danner & Bass Inc. bought a new stake in Cardinal Health during the 4th quarter worth approximately $35,000. Kentucky Trust Co bought a new stake in shares of Cardinal Health during the fourth quarter valued at approximately $41,000. Finally, HHM Wealth Advisors LLC boosted its stake in shares of Cardinal Health by 57.6% in the 4th quarter. HHM Wealth Advisors LLC now owns 394 shares of the company's stock valued at $47,000 after purchasing an additional 144 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on the company. Wells Fargo & Company boosted their price target on Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 4th. Bank of America upgraded shares of Cardinal Health from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $132.00 to $145.00 in a research report on Monday, January 6th. Evercore ISI raised Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 target price on the stock in a research report on Tuesday, January 7th. Jefferies Financial Group upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating and increased their price target for the company from $140.00 to $150.00 in a research report on Wednesday, February 5th. Finally, Mizuho boosted their target price on Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a research report on Monday, March 31st. Four equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $140.14.
Get Our Latest Research Report on CAH
Cardinal Health Trading Down 3.5 %
Shares of CAH traded down $4.55 during midday trading on Thursday, hitting $125.90. The stock had a trading volume of 938,148 shares, compared to its average volume of 2,163,447. The business has a 50-day simple moving average of $129.13 and a two-hundred day simple moving average of $122.10. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $139.50. The firm has a market cap of $30.41 billion, a P/E ratio of 23.53, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61.
Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a $0.5056 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.61%. Cardinal Health's payout ratio is 37.69%.
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.